pf-07284892
Showing 1 - 1 of 1
Solid Tumor Trial in United States (PF-07284892, lorlatinib, binimetinib)
Recruiting
- Solid Tumor
- PF-07284892
- +4 more
-
Orange, California
- +6 more
Feb 15, 2022